home.social

#europeanapproval — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #europeanapproval, aggregated by home.social.

fetched live
  1. Tesla has renamed Full Self-Driving as Tesla Assisted Driving on some European websites, including those in Germany, Spain and France.

    Germany’s transport ministry had described the former name as somewhat misleading because the driver still needs to supervise the system.

    The ministry says it assists with tasks such as acceleration and braking rather than driving the car on its own.

    Authorities in Sweden a…

    en.hacks.gr/i-tesla-allazei-to

    #Tesla #AssistedDriving #DriverSupervision #EuropeanApproval

  2. Novo secures European approval for oral Wegovy to extend lead over Lilly

    Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for…
    #Europe #EU #EliLilly #European #Europeanapproval #NovoNordisk #Obesity #regulatoryapproval #TheEuropeanCommission #weightloss #weightlossdrug #WeightManagement
    europesays.com/europe/96269/

  3. Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

    Novartis Pharma AG First gene replacement therapy in the EU for broad population with SMA, including children two…
    #Europe #EU #EuropeanCommission #Europeanapproval #EuropeanUnion #genereplacementtherapy #genetherapy #motorfunction #motorneuron #Novartis #spinalmuscularatrophy #treatmentoption #treatmentoptions
    europesays.com/europe/86554/

  4. Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market

    Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
    #Europe #EU #Europeanapproval #EuropeanCommission #EuropeanUnion #genetherapy #Novartis #raredisease #spinalmuscularatrophy #stocktrades
    europesays.com/europe/85697/

  5. Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

    Novartis Pharma AG First gene replacement therapy in the EU for broad population with SMA, including children two…
    #Europe #EU #EuropeanCommission #Europeanapproval #EuropeanUnion #genereplacementtherapy #genetherapy #motorfunction #motorneuron #Novartis #spinalmuscularatrophy #treatmentoption #treatmentoptions
    europesays.com/europe/84390/

Share on Mastodon

Enter the server where you have an account.